[HTML][HTML] Dysregulation of miRNA expression in cancer associated fibroblasts (CAFs) and its consequences on the tumor microenvironment
M Schoepp, AJ Ströse, J Haier - Cancers, 2017 - mdpi.com
The tumor microenvironment, including cancer-associated fibroblasts (CAF), has developed
as an important target for understanding tumor progression, clinical prognosis and treatment …
as an important target for understanding tumor progression, clinical prognosis and treatment …
Patient selection criteria and midterm clinical outcome for MitraClip therapy in patients with severe mitral regurgitation and severe congestive heart failure
M Neuss, T Schau, M Schoepp, M Seifert… - European journal of …, 2013 - Wiley Online Library
… The median improvement was 97 m (IQR 0–280 m) in the 6 min walk test and 9 (IQR –2
to 25) points in the MLHF questionnaire regarding quality of life. The improvements were …
to 25) points in the MLHF questionnaire regarding quality of life. The improvements were …
MitraClip in CRT non-responders with severe mitral regurgitation
M Seifert, T Schau, M Schoepp, A Arya, M Neuss… - International journal of …, 2014 - Elsevier
… The authors Seifert M, Schau T, Schoepp M, Neuss M and Arya A have no conflicts of
interest. The author Butter C has received Speaker's honoraria and consultancy fee from Abbott …
interest. The author Butter C has received Speaker's honoraria and consultancy fee from Abbott …
A systematic review of procedural complications from transforaminal lumbar puncture for intrathecal nusinersen administration in patients with spinal muscular atrophy
A Grayev, M Schoepp, A Kuner - American Journal of …, 2021 - Am Soc Neuroradiology
BACKGROUND: Spinal muscular atrophy is a progressive neurodegenerative disorder that
can be treated with intrathecal antisense oligonucleotide therapy (nusinersen). However, …
can be treated with intrathecal antisense oligonucleotide therapy (nusinersen). However, …
[HTML][HTML] Coronary calcification in adults with Turner syndrome
M Schoepp, F Hannah-Shmouni, J Matta… - Genetics in …, 2018 - nature.com
Purpose Adults with Turner syndrome (TS) have an increased predisposition to ischemic
heart disease. The quantitative relationship between coronary atherosclerosis and TS has yet …
heart disease. The quantitative relationship between coronary atherosclerosis and TS has yet …
Metabotropic glutamate receptors in the control of mood disorders
…, GJ Marek, BG Johnson, DD Schoepp - CNS & Neurological …, 2007 - ingentaconnect.com
Current treatments for depression are less than optimal in terms of onset of action, response
and remission rates, and side-effect profiles. Glutamate is the major excitatory …
and remission rates, and side-effect profiles. Glutamate is the major excitatory …
Metabotropic glutamate receptors as novel targets for anxiety and stress disorders
…, AM Linden, JA Monn, DD Schoepp - Nature reviews Drug …, 2005 - nature.com
Anxiety and stress disorders are the most commonly occurring of all mental illnesses, and
current treatments are less than satisfactory. So, the discovery of novel approaches to treat …
current treatments are less than satisfactory. So, the discovery of novel approaches to treat …
In vivo pharmacological characterization of the structurally novel, potent, selective mGlu2/3 receptor agonist LY404039 in animal models of psychiatric disorders
…, JP Tizzano, JA Monn, DL McKinzie, DD Schoepp - …, 2007 - Springer
Rationale Data from both preclinical and clinical studies have provided proof of concept that
modulation of limbic and forebrain glutamate, via mGlu2/3 receptor agonists, might provide …
modulation of limbic and forebrain glutamate, via mGlu2/3 receptor agonists, might provide …
Menaquinone as pool quinone in a purple bacterium
B Schoepp-Cothenet, C Lieutaud… - Proceedings of the …, 2009 - National Acad Sciences
Purple bacteria have thus far been considered to operate light-driven cyclic electron transfer
chains containing ubiquinone (UQ) as liposoluble electron and proton carrier. We show that …
chains containing ubiquinone (UQ) as liposoluble electron and proton carrier. We show that …
Longterm outcome after MitraClip therapy in patients with severe mitral regurgitation and severe congestive heart failure compared to predicted survival by Seattle …
T Schau, M Neuss, M Schoepp, M Seifert… - European Heart …, 2013 - academic.oup.com
Aims: The implantation of MitraClip (MC) is a new treatment modality for severe mitral
regurgitation (MR) in patients who are inoperable or at high conventional operative risk. This study …
regurgitation (MR) in patients who are inoperable or at high conventional operative risk. This study …